Search Results - "Şengül, Sevim S"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Prognostic value of metabolic tumor volume and total lesion glycolysis assessed by 18F-FDG PET/CT in endometrial cancer by Erdogan, Mehmet, Erdemoglu, Evrim, Evrimler, Şehnaz, Hanedan, Candost, Şengül, Sevim S

    Published in Nuclear medicine communications (01-11-2019)
    “…OBJECTIVESurgical staging is the most confidential method for prognosis prediction. However, in which stage the surgery is needed and the treatment management…”
    Get full text
    Journal Article
  2. 2

    The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer by Erdogan, Mehmet, Sengul, Sevim S., Cetin, Bulent, Avcı, Mustafa, Yagci, Samet, Ozkoç, Ismail, Barikan, Damla Ezgi, Yildiz, Mustafa

    Published in Annals of nuclear medicine (01-06-2022)
    “…Objective Lutetium-177 (Lu 177 ) prostate-specific membrane antigen (Lu 177 PSMA) is a novel targeted treatment for patients with metastatic…”
    Get full text
    Journal Article
  3. 3

    The role of Ga 68 PSMA PET/CT imaging in Lu 177 PSMA treatment planning in metastatic castration-resistant prostate cancer by Erdogan, Mehmet, Sengul, Sevim S, Cetin, Bulent, Avcı, Mustafa, Yagci, Samet, Ozkoç, Ismail, Barikan, Damla Ezgi, Yildiz, Mustafa

    Published in Annals of nuclear medicine (01-06-2022)
    “…Lutetium-177 (Lu ) prostate-specific membrane antigen (Lu PSMA) is a novel targeted treatment for patients with metastatic castration-resistant prostate cancer…”
    Get full text
    Journal Article